Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

DE:YPH Stock Latest News

Pre-EarningsIs ALPMF a Buy, Before Earnings?3M ago

The FlySangamo files for restructuring, plans asset sales to Lilly, Astellas4M agoLLY SGMO
Company AnnouncementsAstellas Pharma Cuts Director Slate After Outside Director Resigns5M ago
Company AnnouncementsAstellas Launches Five-Year CSP2026 Plan Targeting Pipeline-Led Record Revenues5M ago
Company AnnouncementsAstellas Extends Global Performance-Linked Stock Incentives for Executives5M ago

Astellas Extends Performance-Linked Stock Incentive Plan for Directors in FY2026

Company AnnouncementsAstellas Extends Performance-Linked Stock Incentive Plan for Directors in FY20265M ago

RatingsAstellas Rated Hold as Xtandi Headwinds Offset Pipeline Potential; Price Target Reiterated at ¥2,2005M ago

Company AnnouncementsAstellas Books Major Impairment and Extraordinary Losses in FY2025 Non-Consolidated Results6M ago

Company AnnouncementsAstellas Pharma Announces New Board Slate and Governance Changes for 20266M ago
Pre-EarningsIs ALPMF a Buy, Before Earnings?6M ago
Company AnnouncementsAstellas Highlights R&D Strategy While Flagging Market and Development Risks7M ago
Company AnnouncementsAstellas and HOVON Phase 3 AML Trial for Xospata Misses Survival Goal7M ago

Astellas Flags Risks and Uncertainties Around Sustainability Plans and Pipeline

Company AnnouncementsAstellas Flags Risks and Uncertainties Around Sustainability Plans and Pipeline8M ago

Company AnnouncementsAstellas Settles Myrbetriq Patent Disputes with Lupin and Zydus8M ago

RatingsSolid Near-Term Outperformance but Post-Xtandi Uncertainty Keeps Shares at Hold9M ago

Company AnnouncementsAstellas Lifts FY2025 Outlook on Robust XTANDI and Mirabegron Demand9M ago
Pre-EarningsALPMF Upcoming Earnings Report: What to Expect?9M ago
Company AnnouncementsAstellas and Pfizer Unveil Breakthrough in Bladder Cancer Treatment10M ago
Company AnnouncementsAstellas Pharma Revises FY2025 Financial Forecasts Upward1y ago

Astellas Pharma (ALPMF) Q2 Earnings Cheat Sheet

Pre-EarningsAstellas Pharma (ALPMF) Q2 Earnings Cheat Sheet1y ago

Company AnnouncementsAstellas Pharma’s GLEAM Trial Falls Short of Primary Endpoint in Pancreatic Cancer Study1y ago

Company AnnouncementsAstellas Pharma’s IZERVAY Gains Conditional Approval in Japan for Geographic Atrophy1y ago